KSPI Form 144: 1,000,000 ADSs Proposed Sale Worth $87.24M
Joint Stock Company Kaspi.kz (KSPI) - Form 144 notice discloses a proposed sale of 1,000,000 American depositary shares (ADSs) through Morgan Stanley & Co. LLC, slated approximately for 09/09/2025 on NASDAQ.
Rhea-AI Filing Summary
Joint Stock Company Kaspi.kz (KSPI) - Form 144 notice discloses a proposed sale of 1,000,000 American depositary shares (ADSs) through Morgan Stanley & Co. LLC, slated approximately for 09/09/2025 on NASDAQ. The filing lists an aggregate market value of $87,240,000 for the block and reports 190,784,522 ADSs outstanding. The ADSs were acquired in a private placement from the issuer on 11/22/2006 with cash payment. The filing also itemizes numerous ADS sales by Asia Equity Partners Ltd between 07/14/2025 and 09/09/2025, showing repeated dispositions of ADSs and associated gross proceeds on specific dates.
Positive
- Full compliance with Rule 144 disclosure: acquisition details, broker, planned sale date, and market value are provided
- Transparent history of ADS dispositions by Asia Equity Partners Ltd with specific dates and gross proceeds
Negative
- Large proposed sale of 1,000,000 ADSs (aggregate value $87,240,000) could increase free float in the market
- Frequent prior sales listed between 07/14/2025 and 09/09/2025 indicate ongoing disposals by the named seller
Insights
TL;DR: A material block of 1,000,000 KSPI ADSs (≈$87.24M) is scheduled for sale via Morgan Stanley, with recent continuous disposals by Asia Equity Partners.
The filing is a straightforward Rule 144 notice: it confirms ownership origin (private placement, 11/22/2006) and planned broker-assisted sale on NASDAQ. The stated aggregate market value and the size relative to reported outstanding ADSs provide clear disclosure about potential incremental supply. The included detailed sale-by-sale records from 07/14/2025 to 09/09/2025 document prior distributions and realized gross proceeds on specific dates, allowing precise tracking of recent liquidity events by the named seller.
TL;DR: Filing meets Rule 144 disclosure requirements, showing source of shares and broker arrangement; multiple recent sales are explicitly reported.
The form properly identifies the nature of acquisition (private placement) and payment method (cash), and includes the broker name and intended exchange. The signature/representation language is present, confirming the seller's statement about absence of undisclosed material adverse information. The chronological list of recent sales offers a transparent record of disposals by Asia Equity Partners Ltd without additional commentary or conditions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the KSPI Form 144 disclose about the proposed sale?
How were the ADSs being sold on Form 144 originally acquired?
How many ADSs were outstanding according to the filing?
Does the filing show prior sales of KSPI ADSs by the same seller?
Which broker is handling the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.